The same research group also obtained other promising APS analogues for lung cancer therapy, which showed cytotoxicity on A549 cells, blocked the proliferative effects of nicotine and restored the effectiveness of cisplatin via α7 nAChR antagonism [56,57]. This evidence concerns the gene CHRNA7 and lung carcinoma.